BRIEF-Unifirst Confirms Rejection Of Unsolicited, Non-Binding And Conditional Acquisition Proposal From Cintas Corporation-February 2024-www.financetom.com

BRIEF-Unifirst Confirms Rejection Of Unsolicited, Non-Binding And Conditional Acquisition Proposal From Cintas Corporation

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Unifirst Confirms Rejection Of Unsolicited, Non-Binding And Conditional Acquisition Proposal From Cintas Corporation

Jan 7, 2025 8:41 AM

Jan 7 (Reuters) - UniFirst Corp ( UNF ):

* UNIFIRST CONFIRMS REJECTION OF UNSOLICITED, NON-BINDING

AND

HIGHLY CONDITIONAL ACQUISITION PROPOSAL FROM CINTAS CORPORATION

Source text:

Further company coverage:

Previous page： Top Midday Gainers Next page： Fox, DISH Network Strike Distribution Deal for Fox Nation

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Top Midday Gainers

Mar 12, 2024

01:56 PM EDT, 03/12/2024 (MT Newswires) -- Regulus Therapeutics ( RGLS ) said Tuesday that the second cohort of patients in a phase 1b study of RGLS8429 for Autosomal Dominant Polycystic Kidney Disease showed clear evidence of a mechanistic dose-response over placebo. Shares surged past 86% in recent trading as intraday trading volume soared to over 146 million from a...

Fox, DISH Network Strike Distribution Deal for Fox Nation

Mar 12, 2024

01:53 PM EDT, 03/12/2024 (MT Newswires) -- Fox's (FOX) Fox Nation direct-to-consumer subscription streaming service expanded its distribution to Dish Network's (DISH) Dish TV and Sling TV, Fox Nation said Tuesday. Financial details weren't disclosed. Beginning mid-March, Dish subscribers can add Fox Nation for $5.99 per month, while the service will also be available for the same price to all...

Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing

Mar 12, 2024

01:45 PM EDT, 03/12/2024 (MT Newswires) -- Thomas Richard Kassberg, Chief Business Officer & Executive Vice President, on March 11, 2024, sold 11,509 shares in Ultragenyx Pharmaceutical ( RARE ) for $574,644. Following the Form 4 filing with the SEC, Kassberg has control over a total of 252,823 shares of the company, with 252,823 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1515673/000095017024029780/xslF345X03/ownership.xml...

Sector Update: Consumer

Mar 12, 2024

01:46 PM EDT, 03/12/2024 (MT Newswires) -- Consumer stocks were higher Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.5% and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 0.9%. Redbook US same-store sales rose by 3% from a year earlier in the week ended March 9 after a 3.1% year-over-year increase in the previous...